Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
FDA issues safety warning for newer hepatitis C drugs following patient deaths
Biopharma Dive
Wed, 08/28/19 - 11:02 pm
FDA
hepatitis C
FAERS
AbbVie
Mavyret
Merck
Zepatier
Gilead Sciences
Vosevi
Gilead, Galapagos finalise £4.1bn research and development deal
Pharmaceutical Business Review
Mon, 08/26/19 - 09:21 am
Gilead Sciences
Galapagos
R&D
AbbVie's Rinvoq label portends safety warnings for future JAKs—including Gilead's
Fierce Pharma
Tue, 08/20/19 - 09:45 am
JAK inhibitors
AbbVie
Rinvoq
FDA
Gilead Sciences
FDA AdCom backs Gilead's move to expand Descovy label — but stops short of endorsing broad PrEP use
Endpoints
Thu, 08/8/19 - 12:56 pm
FDA
Gilead Sciences
HIV
Descovy
PrEP
Regulators, Gilead at odds over HIV drug's use in women
Biopharma Dive
Mon, 08/5/19 - 10:31 pm
Gilead Sciences
HIV
Descovy
Gilead looks to Galapagos deal to double research capacity
Fierce Biotech
Wed, 07/31/19 - 10:20 am
Gilead Sciences
Daniel O'Day
Galapagos
R&D
Gilead Sciences Reports Improving Revenue in the 2nd Quarter
Motley Fool
Wed, 07/31/19 - 08:47 am
Gilead Sciences
earnings
Biktarvy
Gilead's exec search won't hurt its deal search: CEO
Fierce Pharma
Wed, 07/31/19 - 08:46 am
Gilead Sciences
M&A
Daniel O'Day
Busy Gilead crew throws struggling biotech a lifeline, with some cash upfront and hundreds of millions in biobucks for HIV deal
Endpoints
Mon, 07/22/19 - 10:08 am
Gilead Sciences
Durect
HIV
hepatitis B
extended release
Novartis licenses out early antiviral work to Gilead
Fierce Biotech
Fri, 07/19/19 - 10:51 am
Gilead Sciences
Novartis
antivirals
These 5 Firms Could Buy Celgene's Otezla Ahead Of The Bristol Merger
Investors Business Daily
Fri, 07/19/19 - 10:44 am
Bristol-Myers Squibb
Celgene
M&A
Otezla
Gilead Sciences
Amgen
Regeneron
Eli Lilly
JNJ
Gilead's Kite builds cell therapy manufacturing quickly even as Yescarta sales grow slowly
Fierce Pharma
Tue, 07/16/19 - 10:54 am
Gilead Sciences
Kte Pharma
Yescarta
CAR-T
cell therapy
Gilead and Novartis Seek to Expand What FDA Considers as Real-World Data and Real-World Evidence
RAPS.org
Mon, 07/15/19 - 07:06 pm
FDA
Gilead Sciences
Novartis
RWE
real world data
real world evidence
Looking to resolve lingering doubts, Gilead unleashes a $5B late-stage cash alliance with Galapagos
Endpoints
Sun, 07/14/19 - 04:01 pm
Gilead Sciences
Galapagos
IPF
osteoarthritis
Christi Shaw, inspired by her sister’s cancer, named CEO of Kite Pharma, Gilead’s anti-cancer unit
Stat
Thu, 07/11/19 - 05:18 pm
Christi Shaw
Kite Pharma
Gilead Sciences
cancer
Pharma CEOs
Faced with a PhIII flop in NASH, Gilead is sequencing 15,000 patients to find new drugs
Endpoints
Thu, 07/11/19 - 10:35 am
Gilead Sciences
NASH
Renown Institute
gene sequencing
Pfizer's Xeljanz drops off top June TV spenders list—and Gilead's Biktarvy fills the void
Fierce Pharma
Thu, 07/11/19 - 09:45 am
AbbVie
Humira
Gilead Sciences
Biktarvy
Truvada
Pfizer
Xeljanz
television ads
DTC ads
Two Experimental Drugs Show Promise in Inhibiting Ebola Virus
BioSpace
Wed, 07/10/19 - 07:34 pm
CDC
ebola virus
Gilead Sciences
remdesivir
Mapp Biopharmaceutical
ZMapp
Gilead and Lyndra Team Up to Develop Long-Acting HIV Therapies
BioSpace
Tue, 07/9/19 - 06:44 pm
Gilead Sciences
Lyndra Therapeutics
HIV
FDA Eliminates REMS for HIV Drug Truvada and its Generics
RAPS.org
Tue, 07/2/19 - 12:06 pm
FDA
Gilead Sciences
Truvada
HIV
REMS
Pages
« first
‹ previous
…
23
24
25
26
27
28
29
30
31
…
next ›
last »